Although the association between TERT expression and the PFS could not be directly assessed in this small cohort, these results suggest that the high expression level of TERT might be involved in resistance to BRAF and MEK inhibitors in patients with BRAF-mutated melanomas. The gene discussed is MAP2K7; the disease is melanoma.